Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: The Business Research Company | PRODUCT CODE: 1670929

Cover Image

PUBLISHER: The Business Research Company | PRODUCT CODE: 1670929

Single-Cell Omics Global Market Report 2025

PUBLISHED:
PAGES: 200 Pages
DELIVERY TIME: 2-10 business days
SELECT AN OPTION
PDF (Single User License)
USD 4490
PDF (Site License)
USD 6490
PDF (Enterprise License)
USD 8490

Add to Cart

Single-cell omics refers to the analysis and profiling of individual cells obtained from diverse populations, enabling the examination and understanding of both healthy and diseased cellular processes at a granular, single-cell level. This approach is instrumental in studying cellular heterogeneity, identifying cell types, conducting disease research, and developing therapeutic interventions.

The primary types of single-cell omics products encompass single-cell genomics, single-cell transcriptomics, single-cell proteomics, and single-cell metabolomics. Single-cell genomics, for instance, is an advanced technique used to classify individual cells, identifying unique cell types and characterizing distinct cellular features. Various technologies are employed in single-cell omics, including cell isolation and sample preparation methods, as well as next-generation sequencing analysis. These technologies find application across diverse fields such as oncology, cell biology, neurology, immunology, and others. End users of single-cell omics products include pharmaceutical and biotechnology companies, academic and research institutions, hospital and diagnostic laboratories, and other relevant entities involved in advancing scientific research and medical applications.

The single-cell omics market research report is one of a series of new reports from The Business Research Company that provides single-cell omics market statistics, including single-cell omics industry global market size, regional shares, competitors with a single-cell omics market share, detailed single-cell omics market segments, market trends and opportunities, and any further data you may need to thrive in the single-cell omics industry. This single-cell omics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The single-cell omics market size has grown rapidly in recent years. It will grow from $2.08 billion in 2024 to $2.41 billion in 2025 at a compound annual growth rate (CAGR) of 15.9%. The growth in the historic period can be attributed to cellular heterogeneity discovery, the emergence of single-cell analysis tools, biomedical research progress, immune system characterization, and the rise of precision medicine

The single-cell omics market size is expected to see rapid growth in the next few years. It will grow to $4.52 billion in 2029 at a compound annual growth rate (CAGR) of 17.0%. The growth in the forecast period can be attributed to clinical adoption and diagnostics, integration with multi-omics approaches, application in regenerative medicine, drug development and discovery, cellular therapies and immunotherapies. Major trends in the forecast period include in vivo single-cell studies, single-cell omics in infectious disease research, microfluidics and single-cell sorting, single-cell multi-omics integration, and spatial single-cell profiling.

The increasing incidence of cancer is anticipated to drive the growth of the single-cell omics market in the future. Cancer encompasses a range of diseases that can arise in almost any organ or tissue in the body when abnormal cells grow uncontrollably, breach their normal boundaries, and either spread to other organs or invade nearby tissues. The identification of biomarkers for cancer diagnosis, prognosis prediction, and the discovery of new therapeutic targets in specific clinical cohorts has heavily relied on single-cell omics data. For example, in May 2024, the National Institutes of Health, a U.S. government agency, reported that as of January 2022, around 18.1 million individuals in the United States were living as cancer survivors. This figure is projected to increase to 22.5 million by 2032. Thus, the rising prevalence of cancer is propelling the growth of the single-cell omics market.

The increasing number of clinical trials is also expected to propel the growth of the single-cell omics market. Clinical trials, essential research studies conducted on human subjects to evaluate the safety and efficacy of medical interventions, treatments, or drugs, have seen a substantial surge. The application of single-cell omics in clinical trials facilitates detailed analyses of individual cells, offering valuable insights into cellular heterogeneity and enhancing precision medicine approaches. As of May 17, 2023, Xtalks reported that there are 452,604 registered clinical trials globally on ClinicalTrials.gov, representing a significant increase from the over 365,000 registered trials reported in early 2021. This surge in clinical trials serves as a driving factor for the growth of the single-cell omics market.

Product innovation stands out as a pivotal trend gaining traction in the single-cell omics market, with major companies actively pursuing the development of cutting-edge products to maintain their market positions. A notable example is Deepcell, a US-based software provider specializing in single-cell dimensional morphology analysis, which, in May 2023, introduced the REM-I Platform. This platform represents a scalable solution for single-cell imaging, high-dimensional analysis, and cell sorting, providing unprecedented insights into cell biology. The REM-I Platform is poised to catalyze new discoveries across various domains, including cancer biology, developmental biology, stem cell biology, gene therapy, and functional screening. Its unique combination of single-cell imaging, sorting, and high-dimensional analysis is expected to open new avenues for exploration and research.

Major companies in the single-cell omics market are concentrating on the development of advanced kits tailored for single-cell applications to drive market revenues. Sequencing kits, pre-packaged sets of reagents and materials designed for genetic sequencing processes, play a crucial role in streamlining laboratory workflows. Singular Genomics Systems, Inc., a US-based company specializing in novel next-generation sequencing, exemplifies this trend. In February 2023, the company launched the Max Read Kits for single-cell sequencing on the G4 Sequencing Platform. These kits, compatible with popular 10x Genomics assays, offer flexibility for sequencing 4 to 16 samples per run. The Max Read Kits deliver 800 million reads per flow cell with 80% to 90% Q30 quality. Singular Genomics has also elevated the quality specifications of the G4 Sequencing Platform's F2 and F3 flow cells, achieving up to 1.8 billion reads per run on the F3 flow cells for select applications. This strategic focus on advanced sequencing kits aligns with the industry's commitment to enhancing efficiency and precision in single-cell omics applications.

In March 2022, Singleron Biotechnologies, a genomics company based in China, successfully acquired Proteona Pte. Ltd for an undisclosed sum. This strategic acquisition was driven by Singleron's objective to extend its global footprint and gain access to Proteona's cutting-edge technologies specialized in single-cell multi-omic analysis. Proteona, headquartered in Singapore, is a precision medicine firm recognized for its proficiency in single-cell proteogenomic analysis.

Major companies operating in the single-cell omics market include Danaher Corporation, Merck KGaA, Becton Dickinson and Company, GE HealthCare Technologies Inc., Thermo Fischer Scientific Inc., Agilent Technologies Inc., Sartorius AG, Illumina Inc., PerkinElmer Inc., Bio-Rad Laboratories Inc., Qiagen N.V, DiaSorin S.p.A., Tecan Group Ltd., BGI Genomics Co. Ltd., Promega Corporation, 10x Genomics Inc., Takara Bio Inc., NanoString Technologies Inc., Vizgen, HiFiBiO Therapeutics, Deepcell, Immunai, Mission Bio Inc., Standard BioTools Inc., CYTENA GmbH, Celsius Therapeutics, Scailyte AG, Single Cell Discoveries, ImmunoScape Pte. Ltd., Nodexus Inc., 1CellBio Inc.

North America was the largest region in the single-cell omics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the single-cell omics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the single-cell omics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada.

The single-cell omics market includes revenues earned by entities through single-cell sorting and isolation, single-cell sample preparation kits, and related single-cell data analysis software. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Single-Cell Omics Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on single-cell omics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for single-cell omics ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The single-cell omics market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Product: Single-Cell Genomics; Single-Cell Transcriptomics; Single-Cell Proteomics; Single-Cell Metabolomics
  • 2) By Technology: Cell Isolation Technologies; Sample Preparation Technologies; Analysis Of Next-Generation Sequencing
  • 3) By Application: Oncology; Cell Biology; Neurology; Immunology
  • 4) By End-User: Pharmaceutical And Biotechnology Companies; Academic And Research Organizations; Hospital And Diagnostic Laboratories; Other End Users
  • Subsegments:
  • 1) By Single-Cell Genomics: Whole Genome Sequencing (WGS); Targeted Sequencing; Single-Cell DNA Analysis Kits
  • 2) By Single-Cell Transcriptomics: RNA Sequencing (RNA-seq); Quantitative PCR (qPCR) For Single Cells; Single-Cell Gene Expression Analysis Kits
  • 3) By Single-Cell Proteomics: Mass Spectrometry-Based Proteomics; Antibody-Based Protein Analysis; Single-Cell Protein Analysis Kits
  • 4) By Single-Cell Metabolomics: Mass Spectrometry For Metabolites; Nuclear Magnetic Resonance (NMR) Metabolomics; Single-Cell Metabolite Profiling Kits
  • Companies Mentioned: Danaher Corporation; Merck KGaA; Becton Dickinson and Company; GE HealthCare Technologies Inc.; Thermo Fischer Scientific Inc.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.
Product Code: r25300

Table of Contents

1. Executive Summary

2. Single-Cell Omics Market Characteristics

3. Single-Cell Omics Market Trends And Strategies

4. Single-Cell Omics Market - Macro Economic Scenario including the impact of Interest Rates, Inflation, Geopolitics and Covid And Recovery on the Market

5. Global Single-Cell Omics Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Single-Cell Omics PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Single-Cell Omics Market Growth Rate Analysis
  • 5.4. Global Single-Cell Omics Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Single-Cell Omics Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Single-Cell Omics Total Addressable Market (TAM)

6. Single-Cell Omics Market Segmentation

  • 6.1. Global Single-Cell Omics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Single-Cell Genomics
  • Single-Cell Transcriptomics
  • Single-Cell Proteomics
  • Single-Cell Metabolomics
  • 6.2. Global Single-Cell Omics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Cell Isolation Technologies
  • Sample Preparation Technologies
  • Analysis Of Next-Generation Sequencing
  • 6.3. Global Single-Cell Omics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Oncology
  • Cell Biology
  • Neurology
  • Immunology
  • 6.4. Global Single-Cell Omics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Pharmaceutical And Biotechnology Companies
  • Academic And Research Organizations
  • Hospital And Diagnostic Laboratories
  • Other End Users
  • 6.5. Global Single-Cell Omics Market, Sub-Segmentation Of Single-Cell Genomics, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Whole Genome Sequencing (WGS)
  • Targeted Sequencing
  • Single-Cell DNA Analysis Kits
  • 6.6. Global Single-Cell Omics Market, Sub-Segmentation Of Single-Cell Transcriptomics, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • RNA Sequencing (RNA-seq)
  • Quantitative PCR (qPCR) For Single Cells
  • Single-Cell Gene Expression Analysis Kits
  • 6.7. Global Single-Cell Omics Market, Sub-Segmentation Of Single-Cell Proteomics, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Mass Spectrometry-Based Proteomics
  • Antibody-Based Protein Analysis
  • Single-Cell Protein Analysis Kits
  • 6.8. Global Single-Cell Omics Market, Sub-Segmentation Of Single-Cell Metabolomics, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Mass Spectrometry For Metabolites
  • Nuclear Magnetic Resonance (NMR) Metabolomics
  • Single-Cell Metabolite Profiling Kits

7. Single-Cell Omics Market Regional And Country Analysis

  • 7.1. Global Single-Cell Omics Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Single-Cell Omics Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Single-Cell Omics Market

  • 8.1. Asia-Pacific Single-Cell Omics Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Single-Cell Omics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Single-Cell Omics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Single-Cell Omics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Single-Cell Omics Market

  • 9.1. China Single-Cell Omics Market Overview
  • 9.2. China Single-Cell Omics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Single-Cell Omics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Single-Cell Omics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Single-Cell Omics Market

  • 10.1. India Single-Cell Omics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Single-Cell Omics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Single-Cell Omics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Single-Cell Omics Market

  • 11.1. Japan Single-Cell Omics Market Overview
  • 11.2. Japan Single-Cell Omics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Single-Cell Omics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Single-Cell Omics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Single-Cell Omics Market

  • 12.1. Australia Single-Cell Omics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Single-Cell Omics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Single-Cell Omics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Single-Cell Omics Market

  • 13.1. Indonesia Single-Cell Omics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Single-Cell Omics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Single-Cell Omics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Single-Cell Omics Market

  • 14.1. South Korea Single-Cell Omics Market Overview
  • 14.2. South Korea Single-Cell Omics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Single-Cell Omics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Single-Cell Omics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Single-Cell Omics Market

  • 15.1. Western Europe Single-Cell Omics Market Overview
  • 15.2. Western Europe Single-Cell Omics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Single-Cell Omics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Single-Cell Omics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Single-Cell Omics Market

  • 16.1. UK Single-Cell Omics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Single-Cell Omics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Single-Cell Omics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Single-Cell Omics Market

  • 17.1. Germany Single-Cell Omics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Single-Cell Omics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Single-Cell Omics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Single-Cell Omics Market

  • 18.1. France Single-Cell Omics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Single-Cell Omics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Single-Cell Omics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Single-Cell Omics Market

  • 19.1. Italy Single-Cell Omics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Single-Cell Omics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Single-Cell Omics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Single-Cell Omics Market

  • 20.1. Spain Single-Cell Omics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Single-Cell Omics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Single-Cell Omics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Single-Cell Omics Market

  • 21.1. Eastern Europe Single-Cell Omics Market Overview
  • 21.2. Eastern Europe Single-Cell Omics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Single-Cell Omics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Single-Cell Omics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Single-Cell Omics Market

  • 22.1. Russia Single-Cell Omics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Single-Cell Omics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Single-Cell Omics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Single-Cell Omics Market

  • 23.1. North America Single-Cell Omics Market Overview
  • 23.2. North America Single-Cell Omics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Single-Cell Omics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Single-Cell Omics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Single-Cell Omics Market

  • 24.1. USA Single-Cell Omics Market Overview
  • 24.2. USA Single-Cell Omics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Single-Cell Omics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Single-Cell Omics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Single-Cell Omics Market

  • 25.1. Canada Single-Cell Omics Market Overview
  • 25.2. Canada Single-Cell Omics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Single-Cell Omics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Single-Cell Omics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Single-Cell Omics Market

  • 26.1. South America Single-Cell Omics Market Overview
  • 26.2. South America Single-Cell Omics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Single-Cell Omics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Single-Cell Omics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Single-Cell Omics Market

  • 27.1. Brazil Single-Cell Omics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Single-Cell Omics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Single-Cell Omics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Single-Cell Omics Market

  • 28.1. Middle East Single-Cell Omics Market Overview
  • 28.2. Middle East Single-Cell Omics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Single-Cell Omics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Single-Cell Omics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Single-Cell Omics Market

  • 29.1. Africa Single-Cell Omics Market Overview
  • 29.2. Africa Single-Cell Omics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Single-Cell Omics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Single-Cell Omics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Single-Cell Omics Market Competitive Landscape And Company Profiles

  • 30.1. Single-Cell Omics Market Competitive Landscape
  • 30.2. Single-Cell Omics Market Company Profiles
    • 30.2.1. Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Merck KGaA Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Becton Dickinson and Company Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. GE HealthCare Technologies Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Thermo Fischer Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Single-Cell Omics Market Other Major And Innovative Companies

  • 31.1. Agilent Technologies Inc.
  • 31.2. Sartorius AG
  • 31.3. Illumina Inc.
  • 31.4. PerkinElmer Inc.
  • 31.5. Bio-Rad Laboratories Inc.
  • 31.6. Qiagen N.V
  • 31.7. DiaSorin S.p.A.
  • 31.8. Tecan Group Ltd.
  • 31.9. BGI Genomics Co. Ltd.
  • 31.10. Promega Corporation
  • 31.11. 10x Genomics Inc.
  • 31.12. Takara Bio Inc.
  • 31.13. NanoString Technologies Inc.
  • 31.14. Vizgen
  • 31.15. HiFiBiO Therapeutics

32. Global Single-Cell Omics Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Single-Cell Omics Market

34. Recent Developments In The Single-Cell Omics Market

35. Single-Cell Omics Market High Potential Countries, Segments and Strategies

  • 35.1 Single-Cell Omics Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Single-Cell Omics Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Single-Cell Omics Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!